U.S. market Closed. Opens in 2 days 1 hour 46 minutes

ATXI | Avenue Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cost of RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/A
Gross ProfitN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Expenses14.54M8.04M3.74M5.21M26.27M21.82M11.42M2.38M4.84M
Selling, General & Admin4.18M5.34M2.48M2.35M3.07M4.12M3.62M997.00K882.00K
Research & Development10.36M2.70M1.25M2.87M23.19M17.70M7.80M1.38M3.96M
Other Operating ExpensesN/AN/AN/AN/AN/A175.00KN/AN/AN/A
Operating Income-14.54M-8.04M-3.74M-5.21M-26.27M-21.82M-11.42M-2.38M-4.84M
Other Expenses / Income4.05M4.44M7.00K62.00K357.00K268.00K-837.00K-800.00K-383.00K
Before Tax Income-10.49M-3.60M-3.73M-5.15M-25.91M-21.55M-12.26M-3.18M-5.23M
Income Tax Expenses-111.00K-5.65M-7.00K-62.00K-357.00K-268.00KN/AN/AN/A
Net Income-10.38M2.05M-3.72M-5.09M-25.55M-21.28M-12.26M-3.18M-5.23M
Interest ExpensesN/A1.16MN/AN/AN/AN/A375.00K612.00K-383.00K
Basic Shares Outstanding141.00K2.19M1.13M1.10M1.05M682.61K442.33K8.84M8.34M
Diluted Shares Outstanding141.22K2.19M1.13M1.10M1.05M682.61K442.33K8.84M8.34M
EBITDA4.16M-8.02M-3.74M-5.21M-26.27M-21.55M-11.88M-2.38M-5.61M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-10.49M-2.44M-3.73M-5.15M-25.91M-21.55M-11.88M-2.56M-5.61M
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙